Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
**Alzheimer’s Disease | **Alzheimer’s Disease | ||
| - | ***[[ | + | ***[[2ace|Acetylcholinesterase from Torpedo Californica]] |
***[[Acetylcholinesterase]] | ***[[Acetylcholinesterase]] | ||
| + | ***[[Acetylcholine]] | ||
| + | ***[[Flexibility of aromatic residues in acetylcholinesterase|Flexibility of Aromatic Residues in AChE]] | ||
***[[Amyloid Beta]] | ***[[Amyloid Beta]] | ||
| + | ***[[Acetylcholine binding protein]] (AChBP) | ||
| + | ***[[Butyrylcholinesterase]] (BChE) | ||
| + | ***Drug Compounds & Substrates | ||
| + | ****[[AChE_bivalent_inhibitors|Bivalent Inhibitors of Acetylcholinesterase]] | ||
| + | ****[[AChE_bivalent_inhibitors_%28Part_II%29|Bivalent Inhibitors of Acetylcholinesterase, Part II]] | ||
| + | ****[[AChE_inhibitors_and_substrates|Inhibitors and Substrates of Acetylcholinesterase]] | ||
| + | ****[[ AChE_inhibitors_and_substrates_%28Part_II%29| Inhibitors and Substrates of Acetylcholinesterase, Part II]] | ||
| + | ****[[ AChE_inhibitors_and_substrates_%28Part_III%29| Inhibitors and Substrates of Acetylcholinesterase, Part III]] | ||
| + | ****Specific Examples: | ||
| + | *****[[1eve|Aricept Complexed with Acetylcholinesterase]] | ||
| + | *****[[2dfp|DFP (Aged) Complexed with Acetylcholinesterase]] | ||
| + | *****[[1ax9|Edrophonium Complexed with Acetylcholinesterase]] or [[2ack|Here]] | ||
| + | *****[[2j3q|Fluorophore Thioflavin T Complexed with Acetylcholinesterase]] | ||
| + | *****[[1dx6|Galanthamine Complexed with Acetylcholinesterase]] | ||
| + | *****[[1vot|Huperzine A Complexed with Acetylcholinesterase]] | ||
| + | *****[[1w6r|Iminium Galanthamine Derivative bound to Acetylcholinesterase]] or [[1w4l|Here]], or [[1w76|Here]]. | ||
| + | *****[[1gqs|NAP Complexed with Acetylcholinesterase]] | ||
| + | *****[[1vxr|O-tthylmethylphosphonylated Acetylcholinesterase]] | ||
| + | *****[[2wfz|Soman Complexed with Acetylcholinesterase]] or [[2wg0|Here]], or [[2wg1|Here]], or [[1cfj|Here]], or [[1som|Here]]. | ||
| + | *****[[1acj|Tacrine Complexed with Acetylcholinesterase]] | ||
| + | **** Bivalent Inhibitors | ||
| + | *****[[1u65|Anticancer Prodrug CPT-11 Complexed with Acetylcholinesterase]] | ||
| + | *****[[1eve|Aricept Complexed with Acetylcholinesterase]] | ||
| + | *****[[1w4l|Bis-Acting Galanthamine Derivative Complexed with Acetylcholinesterase]], or [[1w76|Here]], or [[1w6r|Here]] | ||
| + | *****[[2cmf|Bis-Tacrine Derivative Complexed with Acetylcholinesterase]] or [[2ckm|Here]] or [[1odc|Here]] | ||
| + | *****[[1acl|Bisquaternary Decamethonium Complexed with Acetylcholinesterase]] | ||
| + | *****[[1e3q|BW284C51 Complexed with Acetylcholinesterase]] | ||
| + | *****[[1zgb|Hupyridone Derivative Complexed with Acetylcholinesterase]], or [[1zgc|Here]], or [[1h22|Here]], or [[1h23|Here]] | ||
| + | *****[[1ut6|N-9-(1',2',3',4'-TETRAHYDROACRIDINYL)-1,8-DIAMINOOCTANE Complexed with Acetylcholinesterase]] | ||
| + | *****[[1jjb|PEG-SH Complexed with Acetylcholinesterase]] | ||
***[[Gamma-Secratase]] | ***[[Gamma-Secratase]] | ||
***Glutamate Receptor | ***Glutamate Receptor | ||
****[[Glutamate receptor (GluA2)]] | ****[[Glutamate receptor (GluA2)]] | ||
****[[Molecular_Playground/Glutamate_Receptor|Glutamate Receptor]] | ****[[Molecular_Playground/Glutamate_Receptor|Glutamate Receptor]] | ||
| - | ***[[1vot|Huperzine A Complexed with Acetylcholinesterase]] | ||
**Anemia | **Anemia | ||
Revision as of 15:16, 26 September 2010
The following is a list of major pharmaceutical compound targets, drugs, and information organized by disease.
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
